(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 26.45% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.58%, and it is also forecast to beat the US market's average forecast revenue growth rate of 21.94%.
Glaukos's revenue in 2026 is $507,442,000.On average, 18 Wall Street analysts forecast GKOS's revenue for 2026 to be $36,364,886,558, with the lowest GKOS revenue forecast at $34,662,596,578, and the highest GKOS revenue forecast at $37,808,145,036. On average, 17 Wall Street analysts forecast GKOS's revenue for 2027 to be $46,350,376,705, with the lowest GKOS revenue forecast at $40,724,282,186, and the highest GKOS revenue forecast at $50,229,460,558.
In 2028, GKOS is forecast to generate $60,518,122,104 in revenue, with the lowest revenue forecast at $52,018,287,968 and the highest revenue forecast at $69,636,495,588.